You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 7, August 20, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pain Management and Chemical Dependency

Evolving Perspectives

Russell K. Portenoy, MD; Vincent Dole, MD; Herman Joseph, PhD; Joyce Lowinson, MD; Carolyn Rice; Sharon Segal, RN, MS; Beverly L. Richman, MD

JAMA. 1997;278(7):592-593.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ON NOVEMBER 21-23, 1996, the first conference designed to explore the connections between pain management and chemical dependency was held in New York City. This conference, which was organized by the newly formed Pain Management and Chemical Dependency Working Group, drew an international audience of 525 physicians, nurses, and other health care professionals. They came to fill gaps in their knowledge of pain management and addiction medicine and to take a first step in reversing the long-standing negative effects caused by the historical lack of communication that exists between these disciplines. The enthusiastic response to this initial effort was a strong affirmation of the need for change.

Nature of the Problem

Pain management and addiction medicine are both young and dynamic fields that share a profound concern with the human response to opioids and other potentially abusable drugs.1 In the clinical arena, both pain specialists and specialists in addiction medicine . . . [Full Text PDF of this Article]


Author Affiliations

for the Pain Management and Chemical Dependency Working Group

From the Pain and Palliative Care Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center (Dr Portenoy); Rockefeller University (Drs Dole and Joseph); New York State Office of Alcoholism and Substance Abuse Services (Dr Joseph); and Beth Israel Medical Center (Mss Rice and Segal and Dr Richman), New York, NY.


Footnotes

A complete list of the participants in the Pain Management and Chemical Dependency Working Group appears at the end of this article.

Reprints: Russell K. Portenoy, MD, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Ave at 16th Street, New York, NY 10003.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Pain Management and Chemical Dependency
Jon Streltzer, Charles D. Donohoe, Daniel J. Murphy, and Russell L. Portenoy
JAMA. 1998;279(1):17-18.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.